BNGO logo

BNGO
Bionano Genomics Inc

101,512
Mkt Cap
$15.67M
Volume
279,441.00
52W High
$22.80
52W Low
$1.45
PE Ratio
-0.10
BNGO Fundamentals
Price
$1.49
Prev Close
$1.54
Open
$1.57
50D MA
$1.85
Beta
1.71
Avg. Volume
501,549.83
EPS (Annual)
-$88.13
P/B
0.29
Rev/Employee
$307,760.00
Loading...
Loading...
News
all
press releases
iBio, Inc. (IBIO) Reports Q1 Loss
iBio (IBIO) delivered earnings and revenue surprises of -57.14% and 0.00%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·8d ago
News Placeholder
More News
News Placeholder
Keros Therapeutics, Inc. (KROS) Reports Q3 Loss, Tops Revenue Estimates
Keros Therapeutics (KROS) delivered earnings and revenue surprises of +83.78% and +86.04%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·15d ago
News Placeholder
Exelixis (EXEL) Beats Q3 Earnings and Revenue Estimates
Exelixis (EXEL) delivered earnings and revenue surprises of +14.71% and +1.49%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·16d ago
News Placeholder
Despite Fast-paced Momentum, Bionano Genomics (BNGO) Is Still a Bargain Stock
Bionano Genomics (BNGO) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.
Zacks·2mo ago
News Placeholder
Bionano Genomics (BNGO) Is Attractively Priced Despite Fast-paced Momentum
Bionano Genomics (BNGO) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.
Zacks·3mo ago
News Placeholder
Bionano Genomics Retail Mood Turns ‘Extremely Bearish’ Amid Revenue Guidance Shortfall
Despite a 46% gross margin improvement and significant cost cuts, the stock fell over 5% on Wednesday before jumping 20% in after-hours trading
Stocktwits·6mo ago
News Placeholder
Absci Corporation (ABSI) Reports Q1 Loss, Misses Revenue Estimates
Zacks·6mo ago
News Placeholder
Earnings Outlook For Bionano Genomics
read more...
Benzinga·1y ago
News Placeholder
Bionano Announces $10 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
SAN DIEGO, April 04, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it has entered into definitive agreements for the purchase and sale of an aggregate of...
Globe Newswire·2y ago
News Placeholder
Bionano Announces Publication Showing that OGM Identifies Genetic Aberrations in Sarcoma Samples that May Lead to Improved Diagnosis but were Missed by Classical Cytogenetics
SAN DIEGO, April 03, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO), today announced the publication of a peer-reviewed study that compared optical genome mapping (OGM) to classical...
Globe Newswire·2y ago

Latest BNGO News

View

Advertisement|Remove ads.

Advertisement|Remove ads.